43 related articles for article (PubMed ID: 12510136)
1. Atrial fibrillation promotion in a rat model of heart failure induced by left ventricle radiofrequency ablation.
Dos Santos L; Antonio EL; Serra AJ; Yoshizaki A; Seibt L; Silva FA; Couto GK; Rossoni LV; Tucci P; de Paola AA; Fenelon G
Int J Cardiol Heart Vasc; 2018 Dec; 21():22-28. PubMed ID: 30258978
[TBL] [Abstract][Full Text] [Related]
2. Electrophysiologic study: its predictive value for ventricular arrhythmias.
Gold DR; Catanzaro JN; Makaryus JN; Waldman C; Sauer WH; Sison C; Makaryus AN; Altman E; Jadonath R; Beldner S
Tex Heart Inst J; 2010; 37(3):291-6. PubMed ID: 20548804
[TBL] [Abstract][Full Text] [Related]
3. Our search for the porcine mother rotor.
Ideker RE; Huang J
Ann Noninvasive Electrocardiol; 2005 Oct; 10(4 Suppl):7-15. PubMed ID: 16274411
[TBL] [Abstract][Full Text] [Related]
4. Do implantable cardioverter defibrillators improve survival in patients with severe left ventricular systolic dysfunction after coronary artery bypass graft surgery?
Fazal IA; Bates MG; Matthews IG; Turley AJ
Interact Cardiovasc Thorac Surg; 2011 Jun; 12(6):1010-6. PubMed ID: 21398652
[TBL] [Abstract][Full Text] [Related]
5. Antiarrhythmic drugs in patients with implantable cardioverter-defibrillators.
Bollmann A; Husser D; Cannom DS
Am J Cardiovasc Drugs; 2005; 5(6):371-8. PubMed ID: 16259525
[TBL] [Abstract][Full Text] [Related]
6. Left ventricular dysfunction is associated with prolonged average ventricular fibrillation cycle length in patients with implantable cardioverter defibrillators.
Fenelon G; Stambler BS; Huvelle E; Brugada P; Stevenson WG;
J Interv Card Electrophysiol; 2002 Dec; 7(3):249-54. PubMed ID: 12510136
[TBL] [Abstract][Full Text] [Related]
7. The mean ventricular fibrillation cycle length: a potentially useful parameter for programming implantable cardioverter defibrillators.
Li H; Easley A; Windle J; Samoil D; Barrington W
Pacing Clin Electrophysiol; 1998 Sep; 21(9):1789-94. PubMed ID: 9744444
[TBL] [Abstract][Full Text] [Related]
8. The impact of catecholamines in patients with or without beta-blockers on the ventricular fibrillation cycle length and ventricular fibrillation cycle length variability.
Min B; Kluger J; Kalus JS; Guertin D; McBride BF; White CM
Ann Noninvasive Electrocardiol; 2005 Jul; 10(3):305-11. PubMed ID: 16029381
[TBL] [Abstract][Full Text] [Related]
9. Is there a correlation between ventricular fibrillation cycle length and electrophysiological and anatomic properties of the canine left ventricle?
Taneja T; Horvath G; Racker DK; Johnson D; Goldberger J; Kadish A
Am J Physiol Heart Circ Physiol; 2004 Aug; 287(2):H823-32. PubMed ID: 15277204
[TBL] [Abstract][Full Text] [Related]
10. Increased cycle length variability during ventricular fibrillation: a novel predictor of arrhythmia recurrence.
Yokoshiki H; Kohya T; Sato M; Sasaki K; Yotsukura A; Sakurai M; Kitabatake A
J Electrocardiol; 2003 Apr; 36(2):137-46. PubMed ID: 12764696
[TBL] [Abstract][Full Text] [Related]
11. Unsuccessful internal defibrillation in Brugada syndrome: focus on refractoriness and ventricular fibrillation cycle length.
Watanabe H; Chinushi M; Sugiura H; Washizuka T; Komura S; Hosaka Y; Furushima H; Watanabe H; Hayashi J; Aizawa Y
J Cardiovasc Electrophysiol; 2005 Mar; 16(3):262-6. PubMed ID: 15817083
[TBL] [Abstract][Full Text] [Related]
12. Is all ventricular fibrillation the same? Influence of mode of induction on characteristics of ventricular fibrillation.
Taneja T; Goldberger J; Johnson D; Kadish A
J Cardiovasc Electrophysiol; 2000 Dec; 11(12):1355-63. PubMed ID: 11196559
[TBL] [Abstract][Full Text] [Related]
13. Heart failure: the electrophysiologic connection.
Marbán E
J Cardiovasc Electrophysiol; 1999 Oct; 10(10):1425-8. PubMed ID: 10515568
[TBL] [Abstract][Full Text] [Related]
14. EXP3174, the AII antagonist human metabolite of losartan, but not losartan nor the angiotensin-converting enzyme inhibitor captopril, prevents the development of lethal ischemic ventricular arrhythmias in a canine model of recent myocardial infarction.
Lynch JJ; Stump GL; Wallace AA; Painter CA; Thomas JM; Kusma SE; Gould RJ; Grossman W
J Am Coll Cardiol; 1999 Sep; 34(3):876-84. PubMed ID: 10483973
[TBL] [Abstract][Full Text] [Related]
15. Initial clinical experience with a new small sized third-generation implantable cardioverter defibrillator: results of a multicenter study. European Ventak Mini Investigator Group.
Fenelon G; Huvelle E; Brugada P
Pacing Clin Electrophysiol; 1997 Dec; 20(12 Pt 1):2967-74. PubMed ID: 9455759
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
